TrademarkOpen
Search / United States / 98434119

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

MINSANU

Allowed — statement of use stage
Third Extension - Granted
Used for: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine…
Show more

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 5 Mar 2024
    Application filed
    New Application Entered
  2. 19 Sep 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 19 Sep 2024
    Office action issued
    Non-Final Action Written
  4. 19 Sep 2024
    Response to office action filed
    Teas Response To Office Action Received
  5. 22 Sep 2024
    Approved for publication
    Approved For Pub - Principal Register
  6. 29 Oct 2024
    Published for opposition
    Published For Opposition
  7. 10 Dec 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 25 Apr 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 30 Oct 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 4 May 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 30 events
2026-05-04Sou Teas Extension Received
2026-05-04Sou Extension 3 Filed
2026-05-04Sou Extension 3 Granted
2026-05-04Notice Of Approval Of Extension Request E-Mailed
2026-01-28Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2026-01-28Attorney/Dom.rep.revoked And/Or Appointed
2026-01-28Teas Change Of Correspondence Received
2026-01-28Teas Withdrawal Of Attorney Received-Firm Retains
2025-10-30Sou Teas Extension Received
2025-10-30Sou Extension 2 Filed
2025-10-30Sou Extension 2 Granted
2025-10-30Notice Of Approval Of Extension Request E-Mailed
2025-04-25Sou Extension 1 Granted
2025-04-25Notice Of Approval Of Extension Request E-Mailed
2025-04-24Sou Teas Extension Received
2025-04-24Sou Extension 1 Filed
2024-12-10Noa Mailed - Sou Required From Applicant
2024-10-29Published For Opposition
2024-10-29Official Gazette Publication Confirmation E-Mailed
2024-10-09Notification Of Notice Of Publication E-Mailed
2024-09-22Approved For Pub - Principal Register
2024-09-19Assigned To Examiner
2024-09-19Non-Final Action Written
2024-09-19Non-Final Action E-Mailed
2024-09-19Notification Of Non-Final Action E-Mailed
2024-09-19Teas Response To Office Action Received
2024-09-19Correspondence Received In Law Office
2024-09-19Teas/Email Correspondence Entered
2024-03-05New Application Entered
2024-03-05New Application Office Supplied Data Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 5 May 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.